Followers | 7 |
Posts | 1577 |
Boards Moderated | 0 |
Alias Born | 02/27/2014 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, March 19, 2015 9:43:50 AM
Endorsements and related activation costs (TV advertising, social media, etc) are good to achieve brand awareness in the first 5 years of a brand. So, Musclepharm is attractive to a buyer that wants to establish themselves long term in the sports nutrition category as a major player to take out Glanbia and Post Holdings.
I find $150 million debt free....meaning $138 million or $11 per share quite realistically.
More than likely Musclepharm won't owe more than $10 million on lawsuit and investigation. The managers may be the ones that will pay, by giving us back stocks, meaning we could get more.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM